תבנית:תרופה/זיפאדהרה 210 מ"ג - Zypadhera 210 mg
ש××× ×× !
×ת×ר××: 9.6.2015 ×תק××× ××××¢× ×× ×©×××ק ×תר××¤× ××פסק ×צ××ת×ת.
×ת×ר××: 9.6.2015 ×תק××× ××××¢× ×× ×©×××ק ×תר××¤× ××פסק ×צ××ת×ת.
×ק×ר: ××©×¨× ××ר×××ת - ××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | N05AH Diazepines, oxazepines, thiazepines and oxepines |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ת×× ×©×¨××¨× - I.M |
| צ×רת ××× ×× | POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSIO |
| ×ת×××× | Zypadhera is indicated for the treatment of schizophrenia.The use of Zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .Zypadhera is NOT to be used in patients whose condition is adequately controlled with oral Zyprexa .
|
| ת×× ×ת:× ×ª×× × ×¡×/תר×פ×/××פ××××¨× 210 ×"× - Zypadhera 210 mg | |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
××× ×¢××× ×ר××¤× |
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| [ ××פ××××¨× 210 ×"×] ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | - |
|---|---|
| ××××¢ ×רשת | - |
| ×©× ××¦×¨× | LILLY S.A., SPAIN |
| ×©× ××¢× ×ר×ש×× | ELI LILLY ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 10/2014. ר×ש××× ×ת×ר××: 11/2015 |
| ת×ר×× ×¢×××× ××ר×× | 9.6.2015 |
××£ ×× × ×צר ×¢× ××× ××× ×××××ר ת×× ×ת ×¢× ×¤×¨×× ×תר×פ×.
- ××£ ×תר×פ×: ××פ××××¨× 210 ×"× - Zypadhera 210 mg
- ××ר××¡× ××× ×ת ×©× ×¤×¨×× ×תר×פ×: × ××ª× ×ער×× ×ת ××£ ×תר××¤× ××¢××. ×××××× ×××××¤× ×ת:
{{תר×פ×/××פ××××¨× 210 ×"× - Zypadhera 210 mg}}
×:
{{תר×פ×/××פ××××¨× 210 ×"× - Zypadhera 210 mg
| ×©× ×פר××ר=×¢×¨× ××ש (××רס ×ת ××¢×¨× ×©×××× ××××ר)
}}
השינוי האחרון נעשה בֹ־29 בפברואר 2024 ב־16:46